This suggests that both FLIPL and HO-1 are two genes that when individually targeted have little or no effect on apoptosis of AML cells, but targeting these two genes in combination would provide a novel mechanism that future more successful therapies must employ to effectively treat AML. The gene discussed is HMOX1; the disease is acute myeloid leukemia.